Human HD WAK Trials Reported at ASN
The FDA requires “proof of concept” trials, and Dr. Victor Gura’s 10-lb. HD wearable artificial kidney has passed its first one. Seven patients wore the WAK for 24 hours, with no adverse events and consistent ultrafiltration rates. Malfunctions such as tubing leaks, CO2 bubbles in the dialysate, and variable blood and dialysate flow rates stopped the trial, and the WAK, fast-tracked by the FDA, will be redesigned before it is tested again.
Read the full article » | Posted 11-11-2015
Related Articles
- Understand Sorbent Dialysis in 8 Minutes Posted 03-13-2025
- Kidney Research UK Invests in a MicroBioSensor to Detect Peritonitis on PD Posted 02-14-2025
- Tom Oostrom of the Dutch Kidney Foundation Shares NeXtkidney Updates Posted 02-14-2025
- University of North Carolina’s GENESIS project to make HD device the size of a cell phone Posted 09-12-2024